市場調查報告書
商品編碼
1439288
脊椎固定裝置 - 全球市場回顧、競爭格局、市場預測 (2030)Spinal Fusion Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
全球脊椎固定器械市場規模將於2023年達到64.9億美元,到2030年將達到84.7億美元,預計2024-2030年期間複合年增長率為4.55%。 脊椎固定裝置的需求不斷增加,主要是由於全球人口老化導致退化性椎間盤疾病、腰椎滑脫、椎間盤突出、椎管狹窄等脊椎疾病的盛行率不斷上升,以及微創手術的需求。是由於增加 此外,產品線的技術進步和新產品的推出也有望推動全球脊椎固定裝置市場的發展。
脊椎固定裝置的市場動態
脊椎融合手術用於改善與脊椎小骨相關的疾病。 此手術涉及固定脊椎中的兩個或多個椎骨,以治療退化性椎間盤疾病、椎骨骨折、脊椎滑脫、椎間盤突出和椎管狹窄等疾病。 近年來,脊椎融合手術的數量逐漸增加。 這是因為與脊椎有關的各種畸形正在增加,主要是由於老化、交通事故、跌倒、暴力等原因。 根據非政府組織澳洲脊髓損傷 (2022) 的統計,約有 15,000 人患有脊髓損傷 (SCI)。 此外,根據該數據,交通事故造成的脊髓外傷佔所有病例的46%,而跌倒造成的脊髓外傷約佔所有病例的36%。 同樣,英國支持脊髓損傷患者的三大慈善機構(脊髓損傷協會、Aspire 和 Back Up)最近的估計(2020-2022 年)表明,英國有多少人維持著改變生活的脊髓每年被診斷患有脊髓損傷的人數為2,500 人,而英國患有脊髓損傷的總人數為500 萬人。 先前人們普遍認為,每年只有 1,000 人受傷或確診,其中包括 NHS(國民醫療服務體系)本身,而脊髓損傷的總人數為 40,000 人。 此外,根據 2019 年國家脊髓損傷資料庫,美國脊髓損傷(SCI)的年發生率約為每百萬人 54 例,每年約有 17,730 例新發 SCI 病例,且SCI不斷增加,數量約為291,000,範圍在249,000至363,000之間。 因此,大量的脊髓損傷病例正在推動全球脊椎固定裝置市場的發展。
此外,全球人口老化負擔日益加重預計也將促進市場成長。 這是因為老年人更容易患上與脊椎相關的疾病。 例如,根據世界衛生組織(2018)的報告,到2050年,全球60歲及以上的人口將達到20億,超過5歲以下兒童的數量。
此外,微創脊椎融合術因其比標準開放式手術方法的優勢而受到歡迎,包括切口更小、肌肉損傷更少、出血更少以及術後住院時間更短。脊椎固定裝置的需求不斷增長也促進了脊椎固定裝置的增長預測期內全球脊椎固定裝置的市場份額。
對脊椎固定裝置的嚴格監管和少量產品召回等某些因素可能會成為脊椎固定裝置市場成長的小障礙。
脊椎固定裝置的細分分析
在脊椎固定裝置產品領域,預期胸腰椎裝置在預測期內將佔據最大的市場份額。 這是因為有多種胸腰椎固定裝置可供選擇。 此外,全球腰椎退化盛行率的上升是推動全球脊椎固定裝置市場細分的主要驅動因素。 例如,根據NCBI 的Ravindra M.V. 及其同事於2018 年發表的題為 "Degenerative Lumbar Spine Disease: Estimating Global Incidence and Worldwide Volume" 的研究,全球每年共有2.66 億人(3.63%)患有腰椎退化性脊柱病。年。(DSD)和腰痛(LBP)。
本報告提供了全球脊椎固定裝置市場的研究和分析,包括市場規模和預測、促進因素和挑戰以及公司和產品概況。
Spinal Fusion Devices Market By Product Type (Thoracolumbar Devices, Cervical Devices, And Interbody Fusion Devices ), By Indication (Degenerative Disc Disorders, Complex Deformity, Trauma & Fractures, And Others), By End-User (Hospitals, Orthopedic Clinics, And Others), by geography is expected to grow at a significant CAGR forecast till 2030 owing to increasing spinal deformities and rise in demand for minimally invasive surgeries
Global Spinal Fusion Devices Market was valued at USD 6.49 billion in 2023, growing at a CAGR of 4.55% during the forecast period from 2024 to 2030 to reach USD 8.47 billion by 2030. The rise in demand for Spinal Fusion Devices is primarily attributed to the rising prevalence of spinal disorders such as degenerative disc disorders, spondylolisthesis, disc herniation, spinal stenosis among the growing old-age population worldwide; increase in demand for minimally invasive surgeries. In addition, technological advancement in the product line, and new product launches among others are also expected to drive the global spinal fusion market.
Spinal Fusion Devices Market Dynamics:
Spinal Fusion surgery is used to rectify disorders related with small bones in the spine. The procedure involves fusion of two or more vertebrae in the vertebral column for the treatment of degenerative discs, fractured vertebra, spondylolisthesis, disc herniation, and spinal canal stenosis, among others. In recent years, the number of spine fusion surgeries has gradually increased. This is owing to the rising prevalence of various spine associated deformities caused primarily due to aging, road traffic crashes, falls or violence. According to the Spinal Cord Injuries Australia, a non-government organization, statistics 2022, approximately 15000 of the population live with a spinal cord injury (SCI). Also according to the data, traumatic spinal cord injury due to traffic crashes contributed to 46% of all the cases whereas falls contributed to around 36% of all the traumatic SCI cases. Similarly, according to the recent estimates (2020-2022) by the three leading charities: Spinal Injuries Association, Aspire and Back Up providing support to the spinal cord injured people in the UK that the number of people injured or diagnosed with a life-changing spinal cord injury in the UK is 2,500 per year, whilst the total number of people living with a spinal cord injury in the UK is 50,000. Previously it was widely believed, including by the (National Health Service) NHS itself, that only 1,000 people were injured or diagnosed each year and that the total number of people living with a spinal cord injury was 40,000. Moreover, according to the National Spinal Cord Injury Database 2019, the annual incidence of spinal cord injury (SCI) is approximately 54 cases per one million people in the United States, or about 17,730 new SCI cases each year and the prevalence is approximately 291,000 persons, with a range from 249,000 to 363,000 persons. Thus, the high cases of spinal cord injuries is propelling the market for the global spinal fusion devices.
Furthermore, rising burden of geriatric population across the globe is also expected to contribute to the market growth. This is because old population are more susceptible for developing spine associated disorders and ailments. For instance, according to WHO 2018 report, by 2050, the world's population aged 60 years and older was expected to total 2 billion and will outnumber children younger than 5 years.
In addition, increasing demand for the minimally invasive spine fusion surgeries due to advantages such as smaller incisions, less muscle damage, decreased blood loss and length of hospital stay following surgery in comparison to standard open approach will also contribute to the global spinal fusion devices during the forecasted period.
Certain factors such as stringent regulation for the spinal devices, and few product recalls may pose a minor hurdle for the growth of the Spinal Fusion Devices market.
Spinal Fusion Devices Segment Analysis:
Spinal Fusion Devices Market By Product Type (Thoracolumbar Devices, Cervical Devices, and Interbody Fusion Devices), By Indication (Degenerative Disc Disorders, Complex Deformity, Trauma & Fractures, and Others), By End-User (Hospitals, Orthopedic Clinics, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
]In Spinal Fusion Devices product segment, the thoracolumbar devices is anticipated to hold the largest market share during the forecasted period. This is due to the availability of a variety of thoracolumbar fixation devices. In addition, rising prevalence of lumbar spine degeneration worldwide are the major driving factors contributing to the segmental growth of the global spinal fusion devices market. For instance, according to a study: Degenerative Lumbar Spine Disease: Estimating Global Incidence and Worldwide Volume by Ravindra M.V. et al., published in NCBI in the year 2018, a total of 266 million individuals (3.63%) worldwide were found to have Lumbar degenerative spine disease (DSD) and low back pain (LBP) annually.
Moreover, recent product approval in is also anticipated to further boost the segmental market of the spinal fusion devices. For instance, in August 2020, Orion Biotech Inc. received the US Food & Drug Administration (FDA) approval for Thoracolumbosacral Pedicle Screw System intended to provide posterior, non-cervical immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine : degenerative spondylolisthesis with objective evidence of neurological impairment; fracture; dislocation; scoliosis; kyphosis; spinal stenosis; tumor; pseudarthrosis and/or failed previous fusion. Therefore, aforementioned factors are likely to propel the segmental growth of Spinal Fusion Devices market.
North America is expected to dominate the Overall Spinal Fusion Devices Market:
Among all the region, North America is expected to dominate the overall Spinal Fusion Devices market during the forecast period. This domination is due to the improved healthcare infrastructure, favourable reimbursement scenario in the region.
Further, in the United States the rising prevalence of low back pain (LBP) among the population is expected to boost the spinal fusion devices market in the region. For instance, according to CDC 2022 report, approximately 25% of U.S. adults report LBP. Also, according to the Canadian Chiropractic Association 2018 data, five in 10 Canadians suffered low back pain.
Moreover, adoption of technologically advancement such as surgical robots for the spine surgery in the region is also expected to grow the spinal fusion devices market. For instance, in 2019, Medtronic launched the Mazor X Stealth(TM) Edition for Robotic-Assisted Spine Surgery. Also, rising spinal fusion surgery volume is also a factor that is anticipated to augment the spinal fusion devices in the region. According to a study: Predicting Trends in Cervical Spinal Surgery in the United States from 2020 to 2040 by Neifert S.N. et al., published in NCBI in the year 2020, it was expected that there would be an increase of 13.3% and 19.3% for anterior cervical discectomy and fusion (ACDF) and posterior cervical decompression and fusion (PCDF) from the year 2020-2040.
Additionally, presence of key market players such as Medtronic, Zimmer Biomet, and Orthofix among other and their strategic business development activities in the region is also a fuelling factor of the spinal fusion devices in the region. For instance, in September 2020, Orthofix Medical Inc. and Neo Medical SA, announced a partnership and investment agreement to develop and market innovative outcome-driven procedural solutions. The collaboration will focus on developing a cervical platform. Also, under the agreement, Orthofix will also exclusively distribute Neo Medical's disruptive value-based thoracolumbar procedure solutions to certain U.S. accounts.
The Asia-Pacific region has the future potential growth for the Global Spinal Fusion Devices. This is due to the rising burden of geriatric population in the region. Rapid urbanization, increase in disposable income, and growing healthcare awareness about are the factors that are likely to drive the market. In addition, increasing prevalence of spine fractures and degenerative disc disorders in the region and improving reimbursement policies for spine surgeries are also expected to surge the market. For instance, in April 2018, Australian Government announced changes to Medicare funded spinal surgery services by introducing new rules to ensure consistent and appropriate claiming.
Spinal Fusion Devices Market Key Players:
Some of the key market players operating in the Spinal Fusion Devices market includes Medtronic, Johnson & Johnson Services, Inc., Zimer Biomet, Stryker, B. Braun Melsungen AG, NuVasive®, Inc., Orthofix Medical Inc., XTANT MEDICAL, and others.
Recent Developmental Activities in the Spinal Fusion Devices Market:
In March 2022, Aurora Spine Corporation successfully launched its Proprietary SiLO(TM) Posterior SI Joint Fusion System.
In September 2020, Royal Biologics acquired FIBRINET. The acquisition comes as part of Royal Biologics' strategic initiative to add novel technologies to its growing portfolio of autologous and live cellular solutions to support orthopedic and spinal fusion.
In July 2020, Zavation Medical Products, LLC. launched Z-Span Expandable Anterior and Lateral Lumbar Plates.
Key Takeaways from the Spinal Fusion Devices Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Spinal Fusion market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global Spinal Fusion Devices Market.
Various opportunities available for the other competitor in the Spinal Fusion Devices Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Spinal Fusion Devices market growth in the coming future?
Target Audience who can be benefited from Spinal Fusion Devices Market Report Study
Spinal Fusion Devices providers
Research organizations and consulting companies
Spinal Fusion-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Spinal Fusion Devices
Various End-users who want to know more about the Spinal Fusion Devices Market and the latest technological developments in the Spinal Fusion Devices market.
Frequently Asked Questions for Spinal Fusion Devices Market:
Spinal Fusion are devices connect two or more vertebrae in the spine to improve stability, correct a deformity or reduce pain.
Global Spinal Fusion Devices Market was valued at USD 6.49 billion in 2023, growing at a CAGR of 4.55% during the forecast period from 2024 to 2030 to reach USD 8.47 billion by 2030.
The major factors driving the demand for Spinal Fusion are the growing geriatric population coupled with the rising spine deformities, increasing demand for minimally invasive surgeries, and the launch of technically advanced products in the market.
Some of the key market players operating in the Spinal Fusion Devices market includes Medtronic, Johnson & Johnson Services, Inc., Zimmer Biomet, Stryker, B. Braun Melsungen AG, NuVasive®, Inc., Orthofix Medical Inc., XTANT MEDICAL, and others.
North America is expected to dominate the overall Spinal Fusion Devices market during the forecast period. This domination is due to the improved healthcare infrastructure, favourable reimbursement scenario in the region. Moreover, presence of key market players, and rising spinal fusion surgeries in the region is also expected to bolster the market.